| Drs Schindler & Deis Pc | |
|
151 N Main St, Garrison, ND 58540-0277 | |
| (701) 463-2224 | |
| (701) 463-2192 |
| Full Name | Drs Schindler & Deis Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 151 N Main St, Garrison, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083791024 | NPI | - | NPPES |
| DEI11845 | Other | ND | BCBS OF ND |
| SCH7191 | Other | ND | BCBS OF ND |
| SCH870397 | Other | ND | ND VISION SERVICES |
| 70486 | Other | ND | BCBS OF ND |
| 60453 | Medicaid | ND | |
| 60629 | Medicaid | ND | |
| DEI870517 | Other | ND | ND VISION SERVICES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 397 (North Dakota) | Primary |
| Provider Name | Thomas L Deis |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205968971 PECOS PAC ID: 2163454919 Enrollment ID: I20050901000403 |
News Archive
Researchers at the University of Montreal's Sainte-Justine Hospital have identified how neural cells are able to build up resistance to opioid pain drugs within hours. "A better understanding of these mechanisms will enable us to design drugs that avoid body resistance to these drugs and produce longer therapeutic responses, including prolonged opioid analgesia", lead author Dr. Graciela Pineyro said.
"[O]ver the past month, [tuberculosis (TB)] has captured high-profile attention from the Washington Post, the New York Times, TIME, NPR, [Agence France-Presse] and other major media, generating big headlines about the rising challenge we face in tackling one of humanity's oldest and most resilient infectious diseases," Jan Gheuens, interim director of the Bill & Melinda Gates Foundation's TB Program, writes in the foundation's "Impatient Optimists" blog.
The health insurance reform legislation enacted last month fully protects the health care benefits of our active duty military, military retirees, and their families. None of its provisions would undermine or affect the excellent health coverage these brave men and women and their families already receive.
StemCells, Inc. announced today that its technology was recently used by independent researchers to achieve the first genetically engineered rat derived from rat embryonic stem (ES) cells. This breakthrough, published this month in the international peer-reviewed journal Nature, opens the door to the types of genetic manipulations previously only possible in mice, and paves the way for modeling a broader range of human diseases with the rat.
› Verified 5 days ago
| Provider Name | Keith L Schindler |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1386776052 PECOS PAC ID: 8921030701 Enrollment ID: I20050901000413 |
News Archive
Researchers at the University of Montreal's Sainte-Justine Hospital have identified how neural cells are able to build up resistance to opioid pain drugs within hours. "A better understanding of these mechanisms will enable us to design drugs that avoid body resistance to these drugs and produce longer therapeutic responses, including prolonged opioid analgesia", lead author Dr. Graciela Pineyro said.
"[O]ver the past month, [tuberculosis (TB)] has captured high-profile attention from the Washington Post, the New York Times, TIME, NPR, [Agence France-Presse] and other major media, generating big headlines about the rising challenge we face in tackling one of humanity's oldest and most resilient infectious diseases," Jan Gheuens, interim director of the Bill & Melinda Gates Foundation's TB Program, writes in the foundation's "Impatient Optimists" blog.
The health insurance reform legislation enacted last month fully protects the health care benefits of our active duty military, military retirees, and their families. None of its provisions would undermine or affect the excellent health coverage these brave men and women and their families already receive.
StemCells, Inc. announced today that its technology was recently used by independent researchers to achieve the first genetically engineered rat derived from rat embryonic stem (ES) cells. This breakthrough, published this month in the international peer-reviewed journal Nature, opens the door to the types of genetic manipulations previously only possible in mice, and paves the way for modeling a broader range of human diseases with the rat.
› Verified 5 days ago
| Provider Name | Leslie Rae Hellebush |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1619317724 PECOS PAC ID: 4880834746 Enrollment ID: I20130717000636 |
News Archive
Researchers at the University of Montreal's Sainte-Justine Hospital have identified how neural cells are able to build up resistance to opioid pain drugs within hours. "A better understanding of these mechanisms will enable us to design drugs that avoid body resistance to these drugs and produce longer therapeutic responses, including prolonged opioid analgesia", lead author Dr. Graciela Pineyro said.
"[O]ver the past month, [tuberculosis (TB)] has captured high-profile attention from the Washington Post, the New York Times, TIME, NPR, [Agence France-Presse] and other major media, generating big headlines about the rising challenge we face in tackling one of humanity's oldest and most resilient infectious diseases," Jan Gheuens, interim director of the Bill & Melinda Gates Foundation's TB Program, writes in the foundation's "Impatient Optimists" blog.
The health insurance reform legislation enacted last month fully protects the health care benefits of our active duty military, military retirees, and their families. None of its provisions would undermine or affect the excellent health coverage these brave men and women and their families already receive.
StemCells, Inc. announced today that its technology was recently used by independent researchers to achieve the first genetically engineered rat derived from rat embryonic stem (ES) cells. This breakthrough, published this month in the international peer-reviewed journal Nature, opens the door to the types of genetic manipulations previously only possible in mice, and paves the way for modeling a broader range of human diseases with the rat.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Drs Schindler & Deis Pc Po Box 277, Garrison, ND 58540-0277 Ph: (701) 463-2224 | Drs Schindler & Deis Pc 151 N Main St, Garrison, ND 58540-0277 Ph: (701) 463-2224 |
News Archive
Researchers at the University of Montreal's Sainte-Justine Hospital have identified how neural cells are able to build up resistance to opioid pain drugs within hours. "A better understanding of these mechanisms will enable us to design drugs that avoid body resistance to these drugs and produce longer therapeutic responses, including prolonged opioid analgesia", lead author Dr. Graciela Pineyro said.
"[O]ver the past month, [tuberculosis (TB)] has captured high-profile attention from the Washington Post, the New York Times, TIME, NPR, [Agence France-Presse] and other major media, generating big headlines about the rising challenge we face in tackling one of humanity's oldest and most resilient infectious diseases," Jan Gheuens, interim director of the Bill & Melinda Gates Foundation's TB Program, writes in the foundation's "Impatient Optimists" blog.
The health insurance reform legislation enacted last month fully protects the health care benefits of our active duty military, military retirees, and their families. None of its provisions would undermine or affect the excellent health coverage these brave men and women and their families already receive.
StemCells, Inc. announced today that its technology was recently used by independent researchers to achieve the first genetically engineered rat derived from rat embryonic stem (ES) cells. This breakthrough, published this month in the international peer-reviewed journal Nature, opens the door to the types of genetic manipulations previously only possible in mice, and paves the way for modeling a broader range of human diseases with the rat.
› Verified 5 days ago